NASDAQ OMX (NASDAQ:NDAQ) announced that Episurf Medical AB (short name: EPIS B), a Small Cap company within the Health Care sector, has started trading of its shares on the main market of NASDAQ OMX Stockholm. Episurf Medical has since 2011 been listed on NASDAQ OMX First North in Stockholm and is, including switches, the twelfth company to list at NASDAQ OMX’s Nordic main markets in 2014 (NASDAQ OMX Stockholm; Helsinki; Copenhagen; and Iceland).
Episurf Medical is a Swedish medical device company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries. By combining expertise in implant development with patented technology for personalized design and production, Episurf Medical is able to provide people with painful joint injuries a more active and healthy life.
“We have a strong technology core and a vision of setting a new standard in inidividually customized orthopaeidics,” said Nina Bake, CEO of Episurf Medical. “Entering the main market gives us a solid foundation for our future growth enabling the company to continue our journey towards becoming a global industry leader.”